Valuation Highnoon Laboratories Limited

Stocks

End-of-day quote Pakistan S.E. Other stock markets 28/07/2026			5-day change	1st Jan Change
996.04 ^PKR	-0.39%		+0.76%	-2.59%

19/05	Highnoon Laboratories Appoints Dr. Shahzad Khan as Managing Director of Highnoon Life Sciences	CI
30/04	Highnoon Laboratories Limited Approves Final Cash Dividend for the Year Ended December 31, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2024	2025	2026	2027	2028
Market Cap ¹	48,650	54,175	52,774	-	-
Change	-	11.36%	-2.59%	-	-
Enterprise Value (EV)	48,650	54,175	52,774	52,774	52,774
Change	-	11.36%	-2.59%	0%	0%
P/E	14.4x	-	-	-	-
PBR	-	-	-	-	-
PEG	-	-	-	-	-
Capitalization / Revenue	-	1.96x	1.74x	1.54x	1.37x
EV / Revenue	-	0x	1.74x	1.54x	1.37x
EV / EBITDA	-	-	-	-	-
EV / EBIT	-	-	-	-	-
EV / FCF	-	-	-	-	-
FCF Yield	-	-	-	-	-
Dividend per Share ²	-	50	45	52	60
Rate of return	-	4.89%	4.52%	5.22%	6.02%
EPS ²	63.95	-	-	-	-
Distribution rate	-	-	-	-	-
Net sales ¹	-	27,706	30,398	34,163	38,399
EBITDA	-	-	-	-	-
EBIT	-	-	-	-	-
Net income	3,389	-	-	-	-
Net Debt	-	-	-	-	-
Reference price ²	918.22	1,022.49	996.04	996.04	996.04
Nbr of stocks (in thousands)	52,983	52,983	52,983	-	-
Announcement Date	26/3/25	7/4/26	-	-	-

¹PKR in Million²PKR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
HIGHNOON LABORATORIES LIMITED	-	-	-	4.5%	190M
ELI LILLY AND COMPANY	35.56x	12.7x	26.67x	0.56%	1,089B
JOHNSON & JOHNSON	28.51x	6.52x	18.04x	2.02%	643B
ABBVIE INC.	32.33x	7.59x	15.6x	2.68%	465B
ROCHE HOLDING AG	19.49x	4.75x	11.79x	2.78%	359B
NOVARTIS AG	22.29x	5.76x	14.37x	2.78%	303B
ASTRAZENECA PLC	21.47x	4.5x	12.72x	1.93%	267B
NOVO NORDISK A/S	14.4x	5.35x	11.02x	3.48%	226B
AMGEN INC.	24.71x	6.49x	11.44x	2.68%	212B
GILEAD SCIENCES, INC.	-47.03x	5.64x	31.15x	2.53%	167B
Average	16.86x	6.59x	16.98x	2.59%	373.13B
Weighted average by Cap.	24.72x	7.97x	18.76x	1.95%